The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
Open accessAbstract
SARS-CoV-2 mRNA vaccination induces robust humoral and cellular immunity in the circulation; however, it is currently unknown whether it elicits effective immune responses in the respiratory tract, particularly against variants of concern (VOCs), including Omicron. We compared the SARS-CoV-2 S–specific total and neutralizing antibody responses, and B and T cell immunity, in the bronchoalveolar lavage fluid (BAL) and blood of COVID-19–vaccinated individuals and hospitalized patients. Vaccinated individuals had significantly lower levels of neutralizing antibody against D614G, Delta (B.1.617.2), and Omicron BA.1.1 in the BAL compared with COVID-19 convalescents despite robust S-specific antibody responses in the blood. Furthermore, mRNA vaccination induced circulating S-specific B and T cell immunity, but in contrast to COVID-19 convalescents, these responses were absent in the BAL of vaccinated individuals. Using a mouse immunization model, we demonstrated that systemic mRNA vaccination alone induced weak respiratory mucosal neutralizing antibody responses, especially against SARS-CoV-2 Omicron BA.1.1 in mice; however, a combination of systemic mRNA vaccination plus mucosal adenovirus-S immunization induced strong neutralizing antibody responses not only against the ancestral virus but also the Omicron BA.1.1 variant. Together, our study supports the contention that the current COVID-19 vaccines are highly effective against severe disease development, likely through recruiting circulating B and T cell responses during reinfection, but offer limited protection against breakthrough infection, especially by the Omicron sublineage. Hence, mucosal booster vaccination is needed to establish robust sterilizing immunity in the respiratory tract against SARS-CoV-2, including infection by the Omicron sublineage and future VOCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine · doi:10.1038/s41591-021-01377-8 · Cited by 3,742
SARS-CoV-2 vaccines in development
Krammer, F. (2020) · Nature · doi:10.1038/s41586-020-2798-3 · Cited by 2,098 · cited 1×
“INTRODUCTION The ongoing coronavirus disease 2019 (COVID-19) pandemic is a global public health crisis, and vaccination is considered the key to ending the pandemic (1, 2).”
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Cao, Y., Wang, J., Jian, F., Xiao, T., Song, W., Yisimayi, A., Huang, W., Li, Q., Wang, P., An, R., et al. (2022) · Nature · doi:10.1038/s41586-021-04385-3 · Cited by 2,006
Self-citationReduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Planas, D., Veyer, D., Baidaliuk, A., Staropoli, I., Guivel-Benhassine, F., Rajah, M. M., Planchais, C., Porrot, F., Robillard, N., Puech, J., et al. (2021) · Nature · doi:10.1038/s41586-021-03777-9 · Cited by 1,992
Adaptive immunity to SARS-CoV-2 and COVID-19
Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Planas, D., Saunders, N., Maes, P., Guivel-Benhassine, F., Planchais, C., Buchrieser, J., Bolland, W.-H., Porrot, F., Staropoli, I., Lemoine, F., et al. (2022) · Nature · doi:10.1038/s41586-021-04389-z · Cited by 1,514
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Liu, L., Wang, P., Nair, M. S., Yu, J., Rapp, M., Wang, Q., Luo, Y., Chan, J. F.-W., Sahi, V., Figueroa, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2571-7 · Cited by 1,349
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Wang, Z., Schmidt, F., Weisblum, Y., Muecksch, F., Barnes, C. O., Finkin, S., Schaefer-Babajew, D., Cipolla, M., Gaebler, C., Lieberman, J. A., et al. (2021) · Nature · doi:10.1038/s41586-021-03324-6 · Cited by 1,343
Cele, S., Jackson, L., Khoury, D. S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J. E., Cromer, D., Scheepers, C., Amoako, D., et al. (2021) · doi:10.1101/2021.12.08.21267417 · Cited by 1,333
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Liu, L., Iketani, S., Guo, Y., Chan, J. F.-W., Wang, M., Liu, L., Luo, Y., Chu, H., Huang, Y., Nair, M. S., et al. (2022) · Nature · doi:10.1038/s41586-021-04388-0 · Cited by 1,290
Tregoning, J. S., Flight, K. E., Higham, S. L., Wang, Z., & Pierce, B. F. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00592-1 · Cited by 1,125
cGAS in action: Expanding roles in immunity and inflammation
Ablasser, A., & Chen, Z. J. (2019) · Science · doi:10.1126/science.aat8657 · Cited by 1,077
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Garcia-Beltran, W. F., St. Denis, K. J., Hoelzemer, A., Lam, E. C., Nitido, A. D., Sheehan, M. L., Berrios, C., Ofoman, O., Chang, C. C., Hauser, B. M., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.033 · Cited by 1,045
Tarke, A., Coelho, C. H., Zhang, Z., Dan, J. M., Yu, E. D., Methot, N., Bloom, N. I., Goodwin, B., Phillips, E., Mallal, S., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.015 · Cited by 858
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Liu, C., Ginn, H. M., Dejnirattisai, W., Supasa, P., Wang, B., Tuekprakhon, A., Nutalai, R., Zhou, D., Mentzer, A. J., Zhao, Y., et al. (2021) · Cell · doi:10.1016/j.cell.2021.06.020 · Cited by 669
Maier, M. A., Jayaraman, M., Matsuda, S., Liu, J., Barros, S., Querbes, W., Tam, Y. K., Ansell, S. M., Kumar, V., Qin, J., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.124 · Cited by 625
Cromer, D., Steain, M., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Kent, S. J., Triccas, J. A., Khoury, D. S., & Davenport, M. P. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00267-6 · Cited by 590
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Sadarangani, M., Marchant, A., & Kollmann, T. R. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00578-z · Cited by 560 · cited 1×
“Similar to what was previously shown ( 3 , 20 ), COVID-19 vaccination induced robust S1 or RBD-specific plasma IgG at levels comparable to severe cases of natural infection (Fig.”
Painter, M. M., Mathew, D., Goel, R. R., Apostolidis, S. A., Pattekar, A., Kuthuru, O., Baxter, A. E., Herati, R. S., Oldridge, D. A., Gouma, S., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.08.001 · Cited by 499
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
Carreño, J. M., Alshammary, H., Tcheou, J., Singh, G., Raskin, A. J., Kawabata, H., Sominsky, L. A., Clark, J. J., Adelsberg, D. C., Bielak, D. A., et al. (2022) · Nature · doi:10.1038/s41586-022-04399-5 · Cited by 478
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2
Goldberg, Y., Mandel, M., Bar-On, Y. M., Bodenheimer, O., Freedman, L. S., Ash, N., Alroy-Preis, S., Huppert, A., & Milo, R. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2118946 · Cited by 467
The first 12 months of COVID-19: a timeline of immunological insights
Carvalho, T., Krammer, F., & Iwasaki, A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00522-1 · Cited by 443
Evolution of enhanced innate immune evasion by SARS-CoV-2
Thorne, L. G., Bouhaddou, M., Reuschl, A.-K., Zuliani-Alvarez, L., Polacco, B., Pelin, A., Batra, J., Whelan, M. V. X., Hosmillo, M., Fossati, A., et al. (2022) · Nature · doi:10.1038/s41586-021-04352-y · Cited by 370
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera
Muik, A., Lui, B. G., Wallisch, A.-K., Bacher, M., Mühl, J., Reinholz, J., Ozhelvaci, O., Beckmann, N., Güimil Garcia, R. D. L. C., Poran, A., et al. (2022) · Science · doi:10.1126/science.abn7591 · Cited by 367
Wu, S., Huang, J., Zhang, Z., Wu, J., Zhang, J., Hu, H., Zhu, T., Zhang, J., Luo, L., Fan, P., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00396-0 · Cited by 290
Self-citationSheikh-Mohamed, S., Isho, B., Chao, G. Y. C., Zuo, M., Cohen, C., Lustig, Y., Nahass, G. R., Salomon-Shulman, R. E., Blacker, G., Fazel-Zarandi, M., et al. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00511-0 · Cited by 274
Planas, D., Veyer, D., Baidaliuk, A., Staropoli, I., Guivel-Benhassine, F., Rajah, M. M., Planchais, C., Porrot, F., Robillard, N., Puech, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.26.445838 · Cited by 266
Immunity to Respiratory Viruses
Kohlmeier, J. E., & Woodland, D. L. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132625 · Cited by 255
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Park, Y.-J., Pinto, D., Walls, A. C., Liu, Z., De Marco, A., Benigni, F., Zatta, F., Silacci-Fregni, C., Bassi, J., Sprouse, K. R., et al. (2022) · Science · doi:10.1126/science.adc9127 · Cited by 249
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Cao, Y., Wang, J., Jian, F., Xiao, T., Song, W., Yisimayi, A., Huang, W., Li, Q., Wang, P., An, R., et al. (2021) · Nature · doi:10.1038/d41586-021-03796-6 · Cited by 227
Self-citationSon, Y. M., Cheon, I. S., Wu, Y., Li, C., Wang, Z., Gao, X., Chen, Y., Takahashi, Y., Fu, Y.-X., Dent, A. L., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abb6852 · Cited by 209
Self-citationIn Vitro Transcription of Long RNA Containing Modified Nucleosides
Pardi, N., Muramatsu, H., Weissman, D., & Karikó, K. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-260-5_2 · Cited by 204
Self-citationConsiderable escape of SARS-CoV-2 Omicron to antibody neutralization
Planas, D., Saunders, N., Maes, P., Guivel‐Benhassine, F., Planchais, C., Buchrieser, J., Bolland, W., Porrot, F., Staropoli, I., Lemoine, F., et al. (2021) · Nature · doi:10.1038/d41586-021-03827-2 · Cited by 197
Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
Israelow, B., Mao, T., Klein, J., Song, E., Menasche, B., Omer, S. B., & Iwasaki, A. (2021) · Science Immunology · doi:10.1126/sciimmunol.abl4509 · Cited by 189
Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
Israelow, B., Mao, T., Klein, J., Song, E., Menasche, B., Omer, S. B., & Iwasaki, A. (2021) · doi:10.1101/2021.05.19.444825 · Cited by 189
Distinct germinal center selection at local sites shapes memory B cell response to viral escape
Adachi, Y., Onodera, T., Yamada, Y., Daio, R., Tsuiji, M., Inoue, T., Kobayashi, K., Kurosaki, T., Ato, M., & Takahashi, Y. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142284 · Cited by 178
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Cele, S., Jackson, L., Khoury, D. S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J. E., Cromer, D., Scheepers, C., Amoako, D. G., et al. (2021) · Nature · doi:10.1038/d41586-021-03824-5 · Cited by 178
Immune signatures underlying post-acute COVID-19 lung sequelae
Cheon, I. S., Li, C., Son, Y. M., Goplen, N. P., Wu, Y., Cassmann, T., Wang, Z., Wei, X., Tang, J., Li, Y., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abk1741 · Cited by 173
Self-citationT resident helper cells promote humoral responses in the lung
Swarnalekha, N., Schreiner, D., Litzler, L. C., Iftikhar, S., Kirchmeier, D., Künzli, M., Son, Y. M., Sun, J., Moreira, E. A., & King, C. G. (2021) · Science Immunology · doi:10.1126/sciimmunol.abb6808 · Cited by 162
Self-citationSARS-CoV-2-specific T cells in infection and vaccination
Bertoletti, A., Le Bert, N., Qui, M., & Tan, A. T. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00743-3 · Cited by 159
Grant, R., Charmet, T., Schaeffer, L., Galmiche, S., Madec, Y., Platen, C. V., Chény, O., Omar, F., David, C., Rogoff, A., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100278 · Cited by 147
Tissue resident memory T cells and viral immunity
Rosato, P. C., Beura, L. K., & Masopust, D. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.11.011 · Cited by 144
León, T. M., Dorabawila, V., Nelson, L., Lutterloh, E. C., Bauer, U. E., Backenson, B. P., Bassett, M. T., Henry, H., Bregman, B., Midgley, C. M., et al. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7104e1 · Cited by 144
Exploiting Mucosal Immunity for Antiviral Vaccines
Iwasaki, A. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112315 · Cited by 138
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment
Li, D., Sempowski, G. D., Saunders, K. O., Acharya, P., & Haynes, B. F. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042420-113838 · Cited by 135
Vaccine-induced COVID-19 mimicry syndrome
Kowarz, E., Krutzke, L., Külp, M., Streb, P., Larghero, P., Reis, J., Bracharz, S., Engler, T., Kochanek, S., & Marschalek, R. (2022) · eLife · doi:10.7554/elife.74974 · Cited by 128
Tissues, not blood, are where immune cells function
Färber, D. L. (2021) · Nature · doi:10.1038/d41586-021-01396-y · Cited by 119
Lim, J. M. E., Tan, A. T., Bert, N. L., Hang, S. K., Low, J. G. H., & Bertoletti, A. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220780 · Cited by 119
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
Carreño, J. M., Alshammary, H., Tcheou, J., Singh, G., Raskin, A. J., Kawabata, H., Sominsky, L. A., Clark, J., Adelsberg, D. C., Bielak, D. A., et al. (2021) · Nature · doi:10.1038/d41586-021-03846-z · Cited by 115
Tissue-specific immunity for a changing world
Weisberg, S. P., Ural, B. B., & Färber, D. L. (2021) · Cell · doi:10.1016/j.cell.2021.01.042 · Cited by 107
Lund, F. E., & Randall, T. D. (2021) · Science · doi:10.1126/science.abg9857 · Cited by 106
COVID-19 vaccine breakthrough infections
Gupta, R. K., & Topol, E. J. (2021) · Science · doi:10.1126/science.abl8487 · Cited by 105
T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant
Choi, S. J., Kim, D.-U., Noh, J. Y., Kim, S., Park, S., Jeong, H. W., & Shin, E. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00838-5 · Cited by 104
Redd, A. D., Nardin, A., Kared, H., Bloch, E. M., Abel, B., Pekosz, A. S., Laeyendecker, O. B., Fehlings, M., Quinn, T. C., & Tobian, A. A. R. (2022) · mBio · doi:10.1128/mbio.03617-21 · Cited by 93
Role of T cell immunity in recovery from influenza virus infection
Sun, J., & Braciale, T. J. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.05.001 · Cited by 91
Self-citationZeng, C., Evans, J. P., Pearson, R., Qu, P., Zheng, Y.-M., Robinson, R., Hall‐Stoodley, L., Yount, J. S., Pannu, S. R., Mallampalli, R. K., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.143213 · Cited by 87
Self-citationNeutralization and Stability of SARS-CoV-2 Omicron VariantPreprint
Zeng, C., Evans, J. P., Qu, P., Faraone, J. N., Zheng, Y.-M., Carlin, C., Bednash, J. S., Zhou, T., Lozanski, G., Mallampalli, R. K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.16.472934 · Cited by 87
Self-citationSsemaganda, A., Nguyen, H. M., Nuhu, F., Jahan, N., Card, C. M., Kiazyk, S. A. K., Severini, G., Keynan, Y., Su, R., Ji, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30913-4 · Cited by 77
Gagné, M., Corbett, K. S., Flynn, B. J., Foulds, K. E., Wagner, D. A., Andrew, S. F., Todd, J.-P. M., Honeycutt, C. C., McCormick, L., Nurmukhambetova, S. T., et al. (2021) · Cell · doi:10.1016/j.cell.2021.12.002 · Cited by 71
Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak
Siddle, K. J., Krasilnikova, L. A., Moreno, G. K., Schaffner, S. F., Vostok, J., Fitzgerald, N. A., Lemieux, J. E., Barkas, N., Loreth, C., Specht, I., et al. (2021) · Cell · doi:10.1016/j.cell.2021.12.027 · Cited by 55
Guerrieri, M., Francavilla, B., Fiorelli, D., Nuccetelli, M., Passàli, F. M., Coppeta, L., Somma, G., Bernardini, S., Magrini, A., & Girolamo, S. D. (2021) · Vaccines · doi:10.3390/vaccines9121499 · Cited by 54
Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
Perotti, M., & Perez, L. H. (2019) · Viruses · doi:10.3390/v12010035 · Cited by 45
Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces neutralizing salivary IgA
Stolovich-Rain, M., Kumari, S., Friedman, A., Kirillov, S., Socol, Y., Billan, M., Pal, R. R., Das, K., Golding, P., Oiknine‐Djian, E., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.933347 · Cited by 24
Local memory CD4 T cell niches in respiratory viral infection
Pruner, K. B., & Pepper, M. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201733 · Cited by 23
Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases
Iyer, S., Yadav, R. T., Agarwal, S., Tripathi, S., & Agarwal, R. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00123-21 · Cited by 22
Co-Ordination of Mucosal B Cell and CD8 T Cell Memory by Tissue-Resident CD4 Helper T Cells
Son, Y. M., & Sun, J. (2021) · Cells · doi:10.3390/cells10092355 · Cited by 21
Self-citationSsemaganda, A., Nguyen, H. M., Nuhu, F., Jahan, N., Card, C. M., Kiazyk, S. A. K., Severini, G., Keynan, Y., Su, R., Ji, H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.07.442971 · Cited by 5
Cited by
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
Mao, T., Israelow, B., Peña-Hernández, M. A., Suberi, A., Zhou, L., Luyten, S., Reschke, M., Dong, H., Homer, R. J., Saltzman, W. M., et al. (2022) · Science · doi:10.1126/science.abo2523 · Cited by 331
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
Goldblatt, D., Alter, G., Crotty, S., & Plotkin, S. A. (2022) · Immunological Reviews · doi:10.1111/imr.13091 · Cited by 298
Hajnik, R. L., Plante, J. A., Liang, Y., Alameh, M.-G., Tang, J., Bonam, S. R., Zhong, C., Adam, A., Scharton, D., Rafael, G. H., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq1945 · Cited by 122
Self-citationIn search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms
Cankat, S., Demael, M. U., & Swadling, L. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-01116-8 · Cited by 84
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
Lee, J., Stewart, C., Schäfer, A., Leaf, E. M., Park, Y.-J., Asarnow, D., Powers, J. M., Treichel, C., Sprouse, K. R., Corti, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49656-5 · Cited by 23
Metadata
- Authors
- Tang, J., Zeng, C., Cox, T. M., Li, C., Son, Y. M., Cheon, I. S., Wu, Y., Behl, S., Taylor, J. J., Chakaraborty, R., Johnson, A. J., Shiavo, D. N., Utz, J. P., Reisenauer, J. S., Midthun, D. E., Mullon, J. J., Edell, E. S., Alameh, M. G., Borish, L., Teague, W. G., Kaplan, M. H., Weissman, D., Kern, R., Hu, H., Vassallo, R., Liu, S.-L., & Sun, J.
- Venue
- Science Immunology
- Published
- 2022-10-28
- Volume
- 7
- Issue
- 76
- Pages
- eadd4853-eadd4853
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W4286217721
- Cited by
- 369
- References
- 67
- FWCI
- 36.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.